MedAvail Holdings, Inc. MDVLQ
0.00
0.00
NaN
as of 24 Sep
- Market cap
- $2.9M
- P/E
- 0.0×
Follow MDVLQ
| Jun '23 | Mar '23 | Dec '22 | Sep '22 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.51 | 0.53 | 0.45 | 3.18 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(5.03) | (4.42) | (1.85) | (5.37) | |
P/B ratio |
0.96 | 5.52 | 0.92 | 1.98 | |
Price to Tangible BV |
0.98 | 6.14 | 0.94 | 2.09 | |
EV/Sales |
0.20 | 0.12 | 0.29 | 2.29 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.28) | (0.13) | (0.26) | (0.87) | |
EV/FCF |
(0.26) | (0.13) | (0.25) | (0.82) | |
Quick Ratio |
3.69 | 3.83 | 2.11 | 4.27 | |
Current Ratio |
6.51 | 6.34 | 4.84 | 5.58 | |
Net Debt/EBITDA |
3.44 | 4.31 | 0.29 | 1.80 | |
Debt/Assets |
5.73% | 4.68% | 16.62% | 21.02% | |
Debt/Equity |
0.07 | 0.40 | 0.26 | 0.33 | |
Asset Turnover |
1.05 | 1.37 | 1.21 | 0.38 | |
Operating CF/Net income |
0.76 | 0.30 | 0.94 | 0.98 | |
Capex/Depreciation |
(0.19) | (0.02) | (0.25) | (0.09) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
35.80% | 28.39% | 1.49% | 1.55% | |
Selling, General and Administrative Expense of Revenue |
1,107.90% | 821.29% | 43.37% | 71.66% | |
Intangible Assets out of Total Assets |
0.02 | 0.01 | 0.01 | 0.03 | |
Share Based Compensation of Revenue |
94.07% | 99.68% | 1.80% | 4.93% | |
Graham Net Nets |
0.92 | 0.04 | 0.86 | 0.34 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(234.26%) | (237.26%) | (294.52%) | (141.75%) | |
Free Cash Flow Yield |
(150.26%) | (180.78%) | (260.16%) | (87.88%) | |
Revenue per Share |
0.23 | 0.39 | 23.44 | 7.16 | |
Operating CF per Share |
(2.44) | (3.25) | (7.89) | (7.23) | |
Capex per Share |
(0.06) | (0.01) | (0.31) | (0.11) | |
Free Cash Flow per Share |
(2.50) | (3.26) | (8.20) | (7.33) | |
Cash per Share |
8.36 | 12.13 | 9.21 | 17.41 | |
Shareholders Equity per Share |
12.82 | 2.60 | 15.83 | 19.56 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
12.82 | 2.60 | 15.83 | 19.56 | |
Free Cash Flow |
(4.49) | (5.23) | (10.79) | (11.74) | |
Working Capital |
22.89 | 27.40 | 22.81 | 32.34 | |
Capital Expenditures |
(0.11) | (0.02) | (0.41) | (0.17) | |
Net Current Asset Value |
20.19 | 0.99 | 16.44 | 20.85 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.27 | 0.03 | 0.01 | 0.01 | |
Net Profit Margin |
(1,429.88%) | (2,795.16%) | (35.89%) | (103.01%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
1.18 | 0.98 | 0.80 | 1.67 | |
Average Payables |
1.83 | 4.71 | 1.65 | 4.54 | |
Average Inventory |
7.84 | 6.89 | 6.37 | 5.33 | |
Average Assets |
41.37 | 31.70 | 35.64 | 50.97 | |
Average Common Equity |
27.92 | 5.39 | 19.95 | 31.26 |
Columns are period end dates